1
|
Dreyer RP, Dharmarajan K, Hsieh AF, Welsh J, Qin L, Krumholz HM. Sex Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia. Circ Cardiovasc Qual Outcomes 2017; 10:CIRCOUTCOMES.116.003271. [PMID: 28506980 DOI: 10.1161/circoutcomes.116.003271] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2016] [Accepted: 04/14/2017] [Indexed: 11/16/2022]
Abstract
BACKGROUND Women have an increased risk of rehospitalization in the immediate postdischarge period; however, few studies have determined how readmission risk dynamically changes on a day-to-day basis over the full year after hospitalization by sex and how these differences compare with the risk for mortality. METHODS AND RESULTS We identified >3 000 000 hospitalizations of patients with a principal discharge diagnosis of heart failure, acute myocardial infarction, or pneumonia and estimated sex differences in the daily risk of rehospitalization/death 1 year after discharge from a population of Medicare fee-for-service beneficiaries aged 65 years and older. We calculated the (1) time required for adjusted rehospitalization/mortality risks to decline 50% from maximum values after discharge, (2) time required for the adjusted readmission risk to approach plateau periods of minimal day-to-day change, and (3) extent to which adjusted risks are greater among recently hospitalized patients versus Medicare patients. We identified 1 392 289, 530 771, and 1 125 231 hospitalizations for heart failure, acute myocardial infarction, and pneumonia, respectively. The adjusted daily risk of rehospitalization varied by admitting condition (hazard rate ratio for women versus men, 1.10 for acute myocardial infarction; hazard rate ratio, 1.04 for heart failure; and hazard rate ratio, 0.98 for pneumonia). However, for all conditions, the adjusted daily risk of death was higher among men versus women (hazard rate ratio women versus with men, <1). For both sexes, there was a similar timing of peak daily risk, half daily risk, and reaching plateau. CONCLUSIONS Although the association of sex with daily risk of rehospitalization varies across conditions, women are at highest risk after discharge for acute myocardial infarction. Future studies should focus on understanding the determinants of sex differences in rehospitalization risk among conditions.
Collapse
Affiliation(s)
- Rachel P Dreyer
- From the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, CT (R.P.D., K.D., A.F.H., J.W., L.Q., H.M.K.); and Department of Emergency Medicine (R.P.D.), Section of Cardiovascular Medicine, Department of Internal Medicine (K.D., H.M.K.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), and Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT.
| | - Kumar Dharmarajan
- From the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, CT (R.P.D., K.D., A.F.H., J.W., L.Q., H.M.K.); and Department of Emergency Medicine (R.P.D.), Section of Cardiovascular Medicine, Department of Internal Medicine (K.D., H.M.K.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), and Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT
| | - Angela F Hsieh
- From the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, CT (R.P.D., K.D., A.F.H., J.W., L.Q., H.M.K.); and Department of Emergency Medicine (R.P.D.), Section of Cardiovascular Medicine, Department of Internal Medicine (K.D., H.M.K.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), and Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT
| | - John Welsh
- From the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, CT (R.P.D., K.D., A.F.H., J.W., L.Q., H.M.K.); and Department of Emergency Medicine (R.P.D.), Section of Cardiovascular Medicine, Department of Internal Medicine (K.D., H.M.K.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), and Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT
| | - Li Qin
- From the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, CT (R.P.D., K.D., A.F.H., J.W., L.Q., H.M.K.); and Department of Emergency Medicine (R.P.D.), Section of Cardiovascular Medicine, Department of Internal Medicine (K.D., H.M.K.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), and Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT
| | - Harlan M Krumholz
- From the Center for Outcomes Research and Evaluation (CORE), Yale New Haven Health, CT (R.P.D., K.D., A.F.H., J.W., L.Q., H.M.K.); and Department of Emergency Medicine (R.P.D.), Section of Cardiovascular Medicine, Department of Internal Medicine (K.D., H.M.K.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), and Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT
| |
Collapse
|
2
|
Dreyer RP, Ranasinghe I, Wang Y, Dharmarajan K, Murugiah K, Nuti SV, Hsieh AF, Spertus JA, Krumholz HM. Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction. Circulation 2015; 132:158-66. [PMID: 26085455 DOI: 10.1161/circulationaha.114.014776] [Citation(s) in RCA: 57] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/09/2014] [Accepted: 05/08/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND Young women (<65 years) experience a 2- to 3-fold greater mortality risk than younger men after an acute myocardial infarction. However, it is unknown whether they are at higher risk for 30-day readmission, and if this association varies by age. We examined sex differences in the rate, timing, and principal diagnoses of 30-day readmissions, including the independent effect of sex following adjustment for confounders. METHODS AND RESULTS We included patients aged 18 to 64 years with a principal diagnosis of acute myocardial infarction. Data were used from the Healthcare Cost and Utilization Project-State Inpatient Database for California (07-09). Readmission diagnoses were categorized by using an aggregated version of the Centers for Medicare and Medicaid Services' Condition Categories, and readmission timing was determined from the day after discharge. Of 42,518 younger patients with acute myocardial infarction (26.4% female), 4775 (11.2%) had at least 1 readmission. The 30-day all-cause readmission rate was higher for women (15.5% versus 9.7%, P<0.0001). For both sexes, readmission risk was highest on days 2 to 4 after discharge and declined thereafter, and women were more likely to present with noncardiac diagnoses (44.4% versus 40.6%, P=0.01). Female sex was associated with a higher rate of 30-day readmission, which persisted after adjustment (hazard ratio, 1.22; 95% confidence interval, 1.15-1.30). There was no significant interaction between age and sex on readmission. CONCLUSIONS In comparison with men, younger women have a higher risk for readmission, even after the adjustment for confounders. The timing of 30-day readmission was similar in women and men, and both sexes were susceptible to a wide range of causes for readmission.
Collapse
Affiliation(s)
- Rachel P Dreyer
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted.
| | - Isuru Ranasinghe
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - Yongfei Wang
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - Kumar Dharmarajan
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - Karthik Murugiah
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - Sudhakar V Nuti
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - Angela F Hsieh
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - John A Spertus
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| | - Harlan M Krumholz
- From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted
| |
Collapse
|
3
|
Dharmarajan K, Hsieh AF, Kulkarni VT, Lin Z, Ross JS, Horwitz LI, Kim N, Suter LG, Lin H, Normand SLT, Krumholz HM. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ 2015; 350:h411. [PMID: 25656852 PMCID: PMC4353309 DOI: 10.1136/bmj.h411] [Citation(s) in RCA: 149] [Impact Index Per Article: 16.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
OBJECTIVE To characterize the absolute risks for older patients of readmission to hospital and death in the year after hospitalization for heart failure, acute myocardial infarction, or pneumonia. DESIGN Retrospective cohort study. SETTING 4767 hospitals caring for Medicare fee for service beneficiaries in the United States, 2008-10. PARTICIPANTS More than 3 million Medicare fee for service beneficiaries, aged 65 years or more, surviving hospitalization for heart failure, acute myocardial infarction, or pneumonia. MAIN OUTCOME MEASURES Daily absolute risks of first readmission to hospital and death for one year after discharge. To illustrate risk trajectories, we identified the time required for risks of readmission to hospital and death to decline 50% from maximum values after discharge; the time required for risks to approach plateau periods of minimal day to day change, defined as 95% reductions in daily changes in risk from maximum daily declines after discharge; and the extent to which risks are higher among patients recently discharged from hospital compared with the general elderly population. RESULTS Within one year of hospital discharge, readmission to hospital and death, respectively, occurred following 67.4% and 35.8% of hospitalizations for heart failure, 49.9% and 25.1% for acute myocardial infarction, and 55.6% and 31.1% for pneumonia. Risk of first readmission had declined 50% by day 38 after hospitalization for heart failure, day 13 after hospitalization for acute myocardial infarction, and day 25 after hospitalization for pneumonia; risk of death declined 50% by day 11, 6, and 10, respectively. Daily change in risk of first readmission to hospital declined 95% by day 45, 38, and 45; daily change in risk of death declined 95% by day 21, 19, and 21. After hospitalization for heart failure, acute myocardial infarction, or pneumonia, the magnitude of the relative risk for hospital admission over the first 90 days was 8, 6, and 6 times greater than that of the general older population; the relative risk of death was 11, 8, and 10 times greater. CONCLUSIONS Risk declines slowly for older patients after hospitalization for heart failure, acute myocardial infarction, or pneumonia and is increased for months. Specific risk trajectories vary by discharge diagnosis and outcome. Patients should remain vigilant for deterioration in health for an extended time after discharge. Health providers can use knowledge of absolute risks and their changes over time to better align interventions designed to reduce adverse outcomes after discharge with the highest risk periods for patients.
Collapse
Affiliation(s)
- Kumar Dharmarajan
- Department of Internal Medicine, Columbia University Medical Center, NY, USA
| | - Angela F Hsieh
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
| | - Vivek T Kulkarni
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
| | - Zhenqiu Lin
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
| | - Joseph S Ross
- Section of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
| | - Leora I Horwitz
- Section of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
| | - Nancy Kim
- Section of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
| | - Lisa G Suter
- Section of Rheumatology, Yale University School of Medicine, New Haven, CT, USA
| | - Haiqun Lin
- Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA
| | | | - Harlan M Krumholz
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
| |
Collapse
|
4
|
Ranasinghe I, Wang Y, Dharmarajan K, Hsieh AF, Bernheim SM, Krumholz HM. Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study. PLoS Med 2014; 11:e1001737. [PMID: 25268126 PMCID: PMC4181962 DOI: 10.1371/journal.pmed.1001737] [Citation(s) in RCA: 74] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2013] [Accepted: 08/14/2014] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Patients aged ≥ 65 years are vulnerable to readmissions due to a transient period of generalized risk after hospitalization. However, whether young and middle-aged adults share a similar risk pattern is uncertain. We compared the rate, timing, and readmission diagnoses following hospitalization for heart failure (HF), acute myocardial infarction (AMI), and pneumonia among patients aged 18-64 years with patients aged ≥ 65 years. METHODS AND FINDINGS We used an all-payer administrative dataset from California consisting of all hospitalizations for HF (n=206,141), AMI (n=107,256), and pneumonia (n=199,620) from 2007-2009. The primary outcomes were unplanned 30-day readmission rate, timing of readmission, and readmission diagnoses. Our findings show that the readmission rate among patients aged 18-64 years exceeded the readmission rate in patients aged ≥ 65 years in the HF cohort (23.4% vs. 22.0%, p<0.001), but was lower in the AMI (11.2% vs. 17.5%, p<0.001) and pneumonia (14.4% vs. 17.3%, p<0.001) cohorts. When adjusted for sex, race, comorbidities, and payer status, the 30-day readmission risk in patients aged 18-64 years was similar to patients ≥ 65 years in the HF (HR 0.99; 95%CI 0.97-1.02) and pneumonia (HR 0.97; 95%CI 0.94-1.01) cohorts and was marginally lower in the AMI cohort (HR 0.92; 95%CI 0.87-0.96). For all cohorts, the timing of readmission was similar; readmission risks were highest between days 2 and 5 and declined thereafter across all age groups. Diagnoses other than the index admission diagnosis accounted for a substantial proportion of readmissions among age groups <65 years; a non-cardiac diagnosis represented 39-44% of readmissions in the HF cohort and 37-45% of readmissions in the AMI cohort, while a non-pulmonary diagnosis represented 61-64% of patients in the pneumonia cohort. CONCLUSION When adjusted for differences in patient characteristics, young and middle-aged adults have 30-day readmission rates that are similar to elderly patients for HF, AMI, and pneumonia. A generalized risk after hospitalization is present regardless of age. Please see later in the article for the Editors' Summary.
Collapse
Affiliation(s)
- Isuru Ranasinghe
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America
| | - Yongfei Wang
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America
| | - Kumar Dharmarajan
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America
- Division of Cardiology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, United States of America
| | - Angela F. Hsieh
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America
| | - Susannah M. Bernheim
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America
| | - Harlan M. Krumholz
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America
- Division of Cardiology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, United States of America
- The Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, United States of America
- Health Policy and Management, School of Public Health, Yale University, New Haven, Connecticut, United States of America
| |
Collapse
|
5
|
Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Suter LG, Bernheim SM, Drye EE, Krumholz HM. Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions. BMJ 2013; 347:f6571. [PMID: 24259033 PMCID: PMC3898430 DOI: 10.1136/bmj.f6571] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To determine whether high performing hospitals with low 30 day risk standardized readmission rates have a lower proportion of readmissions from specific diagnoses and time periods after admission or instead have a similar distribution of readmission diagnoses and timing to lower performing institutions. DESIGN Retrospective cohort study. SETTING Medicare beneficiaries in the United States. PARTICIPANTS Patients aged 65 and older who were readmitted within 30 days after hospital admission for heart failure, acute myocardial infarction, or pneumonia in 2007-09. MAIN OUTCOME MEASURES Readmission diagnoses were classified with a modified version of the Centers for Medicare and Medicaid Services' condition categories, and readmission timing was classified by day (0-30) after hospital discharge. Hospital 30 day risk standardized readmission rates over the three years of study were calculated with public reporting methods of the US federal government, and hospitals were categorized with bootstrap analysis as having high, average, or low readmission performance for each index condition. High and low performing hospitals had ≥ 95% probability of having an interval estimate respectively less than or greater than the national 30 day readmission rate over the three year period of study. All remaining hospitals were considered average performers. RESULTS For readmissions in the 30 days after the index admission, there were 320,003 after 1,291,211 admissions for heart failure (4041 hospitals), 102,536 after 517,827 admissions for acute myocardial infarction (2378 hospitals), and 208,438 after 1,135,932 admissions for pneumonia (4283 hospitals). The distribution of readmissions by diagnosis was similar across categories of hospital performance for all three conditions. High performing hospitals had fewer readmissions for all common diagnoses. Median time to readmission was similar by hospital performance for heart failure and acute myocardial infarction, though was 1.4 days longer among high versus low performing hospitals for pneumonia (P<0.001). Findings were unchanged after adjustment for other hospital characteristics potentially associated with readmission patterns. CONCLUSIONS High performing hospitals have proportionately fewer 30 day readmissions without differences in readmission diagnoses and timing, suggesting the possible benefit of strategies that lower risk of readmission globally rather than for specific diagnoses or time periods after hospital stay.
Collapse
Affiliation(s)
- Kumar Dharmarajan
- Division of Cardiology, Department of Internal Medicine, Columbia University Medical Center, 630 West 168th Street, Box 93, PH 10-203, New York, NY 10032, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Dharmarajan K, Hsieh AF, Lin Z, Kim N, Ross JS, Horwitz LI, Kulkarni V, Suter LG, Bernheim SM, Drye EE, Normand SL, Krumholz HM. Abstract 13: Risks of Death and Hospital Readmission by Time Following Hospitalization for Heart Failure and Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes 2013. [DOI: 10.1161/circoutcomes.6.suppl_1.a13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background:
After hospitalization for heart failure (HF) and acute myocardial infarction (AMI), patients experience increased risk of death and hospital readmission. Defining the trajectory and timing of this period of risk may help guide interventions to improve post-discharge outcomes.
Methods:
We used 2008-10 Medicare data to identify patients ≥65 years discharged alive after HF or AMI hospitalization. Using hazard rates, we characterized the risks of death and first readmission on each day after discharge to describe (1) the maximum daily risks of death and readmission after discharge; (2) risks of death and readmission 1 year after discharge; (3) the time in days after discharge for the risks of death and readmission to reach their maximum daily rates and 50% of their maximum daily rates to characterize the rapidity of decline in risk. We created separate survival models for death and first readmission. Data were censored after 1 year follow up. The readmission model also censored for death prior to readmission.
Results:
Of 878,963 HF hospitalizations, 367,542 (41.8%) died and 618,283 (70.3%) were readmitted in 1 year. Of 350,509 AMI hospitalizations, 90,623 (25.9%) died and 177,031(50.5%) were readmitted in 1 year. The Figure shows hazard rates by time after discharge. For HF, daily risk of death was 0.0056 maximally and 0.0011 at 1 year (19% of maximum). Daily risk of readmission was 0.013 maximally and 0.002 at 1 year (16% of maximum). Daily risk of death was highest 1 day after discharge and 50% less 11 days after discharge. Daily risk of readmission was highest 4 days after discharge and 50% less 49 days after discharge. For AMI, daily risk of death was 0.010 maximally and 0.0004 at 1 year (4% of maximum). Daily risk of readmission was 0.015 maximally and 0.0011 at 1 year (7% of maximum). Daily risk of death was highest 1 day after discharge and 50% less 6 days after discharge. Daily risk of readmission was highest 2 days after discharge and 50% less 13 days after discharge.
Conclusions:
After hospitalization for HF and AMI, risk of death is highest on day 1 after discharge and then declines rapidly. In contrast, risk of readmission peaks later and declines more slowly. This extended period of risk for readmission may justify continued vigilance beyond the 30-day period used by Medicare to evaluate hospital readmission performance.
Collapse
Affiliation(s)
| | - Angela F Hsieh
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | - Zhenqiu Lin
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | - Nancy Kim
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | - Joseph S Ross
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | - Leora I Horwitz
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | | | - Lisa G Suter
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | | | - Elizabeth E Drye
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| | | | - Harlan M Krumholz
- Yale-New Haven Hosp Cntr for Outcomes Rsch and Evaluation, New Haven, CT
| |
Collapse
|
7
|
Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE, Krumholz HM. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013; 309:355-63. [PMID: 23340637 PMCID: PMC3688083 DOI: 10.1001/jama.2012.216476] [Citation(s) in RCA: 734] [Impact Index Per Article: 66.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
IMPORTANCE To better guide strategies intended to reduce high rates of 30-day readmission after hospitalization for heart failure (HF), acute myocardial infarction (MI), or pneumonia, further information is needed about readmission diagnoses, readmission timing, and the relationship of both to patient age, sex, and race. OBJECTIVE To examine readmission diagnoses and timing among Medicare beneficiaries readmitted within 30 days after hospitalization for HF, acute MI, or pneumonia. DESIGN, SETTING, AND PATIENTS We analyzed 2007-2009 Medicare fee-for-service claims data to identify patterns of 30-day readmission by patient demographic characteristics and time after hospitalization for HF, acute MI, or pneumonia. Readmission diagnoses were categorized using an aggregated version of the Centers for Medicare & Medicaid Services' Condition Categories. Readmission timing was determined by day after discharge. MAIN OUTCOME MEASURES We examined the percentage of 30-day readmissions occurring on each day (0-30) after discharge; the most common readmission diagnoses occurring during cumulative periods (days 0-3, 0-7, 0-15, and 0-30) and consecutive periods (days 0-3, 4-7, 8-15, and 16-30) after hospitalization; median time to readmission for common readmission diagnoses; and the relationship between patient demographic characteristics and readmission diagnoses and timing. RESULTS From 2007 through 2009, we identified 329,308 30-day readmissions after 1,330,157 HF hospitalizations (24.8% readmitted), 108,992 30-day readmissions after 548,834 acute MI hospitalizations (19.9% readmitted), and 214,239 30-day readmissions after 1,168,624 pneumonia hospitalizations (18.3% readmitted). The proportion of patients readmitted for the same condition was 35.2% after the index HF hospitalization, 10.0% after the index acute MI hospitalization, and 22.4% after the index pneumonia hospitalization. Of all readmissions within 30 days of hospitalization, the majority occurred within 15 days of hospitalization: 61.0%, HF cohort; 67.6%, acute MI cohort; and 62.6%, pneumonia cohort. The diverse spectrum of readmission diagnoses was largely similar in both cumulative and consecutive periods after discharge. Median time to 30-day readmission was 12 days for patients initially hospitalized for HF, 10 days for patients initially hospitalized for acute MI, and 12 days for patients initially hospitalized for pneumonia and was comparable across common readmission diagnoses. Neither readmission diagnoses nor timing substantively varied by age, sex, or race. CONCLUSION AND RELEVANCE Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge.
Collapse
Affiliation(s)
- Kumar Dharmarajan
- Division of Cardiology, Department of Internal Medicine, Columbia University Medical Center, New York, New York, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|